Natus seeks to grow Grass within expanded neurology business
This article was originally published in Clinica
Natus Medical is to expand its portfolio of neurodiagnostic and monitoring products by agreeing to acquire The Grass Technologies Product Group for $18.6 million. The transaction follows on from Natus's purchase of the Nicolet neurodiagnostic business from CareFusion last year (www.clinica.co.uk, 25 April 2012). Grass, based in West Warwick, Rhode Island, was founded in 1935 by Albert Grass; it specialises in polysomnography and sleep diagnostics, and EEG systems for clinical and research use. The company is currently owned by digital and recording systems manufacturer Astro-Med, which said it was divesting Grass to focus more on other fast-growing business segments.
You may also be interested in...
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.